Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Research suggests regaining weight is common after cessation
Consequently, it is currently not possible to determine the correlation between adverse events experienced during the treatment period and subsequent weight regain after discontinuation
Vial-and-syringe format
Weight loss was also observed, with a modest correlation between alcohol reduction and weight change, suggesting GLP-1RAs may simultaneously target both alcohol use and obesity
If joint pain emerges during your PlexusDx protocol, your care team can adjust your dose trajectory, extend the time between escalations, or recommend concurrent support therapiesall without changing your monthly investment
